Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study.

Bo-Huang LiouHsin-Yun SunChia-Jui YangLing-Shan SyueYu-Lin LeeHung-Jen TangHung-Chin TsaiChi-Ying LinTun-Chieh ChenChun-Yuan LeeSung-Hsi HuangChia-Wei LiuPo-Liang LuShih-Ping LinNing-Chi WangAristine ChengWen-Chien KoShu-Hsing ChengChien-Ching Hungnull null

Published in: Infectious diseases and therapy (2021)

Similar to the response observed among HIV-negative patients, LDV/SOF is effective for HIV-positive patients coinfected with HCV GT2.

Keyphrases

hiv positive
antiretroviral therapy
men who have sex with men
hepatitis c virus
end stage renal disease
south africa
human immunodeficiency virus
ejection fraction
chronic kidney disease
newly diagnosed
hiv infected
hiv testing
peritoneal dialysis
hiv aids